Conti Bellocchi, M.C.; Teso, M.V.; Spagnolo, S.; Manfrin, E.; Sina, S.; Pea, A.; de Pretis, N.; Salvia, R.; Frulloni, L.; Crinò, S.F.
Through-the-Needle Biopsy Revisited: How Patient Selection and Standardization Reduce Adverse Events in Pancreatic Cyst Evaluation. Diagnostics 2025, 15, 3096.
https://doi.org/10.3390/diagnostics15243096
AMA Style
Conti Bellocchi MC, Teso MV, Spagnolo S, Manfrin E, Sina S, Pea A, de Pretis N, Salvia R, Frulloni L, Crinò SF.
Through-the-Needle Biopsy Revisited: How Patient Selection and Standardization Reduce Adverse Events in Pancreatic Cyst Evaluation. Diagnostics. 2025; 15(24):3096.
https://doi.org/10.3390/diagnostics15243096
Chicago/Turabian Style
Conti Bellocchi, Maria Cristina, Maria Vittoria Teso, Sofia Spagnolo, Erminia Manfrin, Sokol Sina, Antonio Pea, Nicolò de Pretis, Roberto Salvia, Luca Frulloni, and Stefano Francesco Crinò.
2025. "Through-the-Needle Biopsy Revisited: How Patient Selection and Standardization Reduce Adverse Events in Pancreatic Cyst Evaluation" Diagnostics 15, no. 24: 3096.
https://doi.org/10.3390/diagnostics15243096
APA Style
Conti Bellocchi, M. C., Teso, M. V., Spagnolo, S., Manfrin, E., Sina, S., Pea, A., de Pretis, N., Salvia, R., Frulloni, L., & Crinò, S. F.
(2025). Through-the-Needle Biopsy Revisited: How Patient Selection and Standardization Reduce Adverse Events in Pancreatic Cyst Evaluation. Diagnostics, 15(24), 3096.
https://doi.org/10.3390/diagnostics15243096
